Finance entity
Every one of those 1 sits in a single category, markets. Docebo is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6.4 for that window.
Last mentioned: Mar 8, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, markets. Docebo is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6.4 for that window. They are better corroborated than the beat average, carrying 3 original sources each against 2.6 for the same window. We currently track 1 Finance story that mention Organogenesis, all published on March 8, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 55 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Organogenesis. Shared-story counts are live from our verified record — not editorial picks.
Analyst firm Wall Street Zen has issued significant rating upgrades for Weatherford International, Docebo, and Organogenesis. These shifts to 'Buy' and 'Strong-Buy' status signal a positive fundamental outlook across the energy, enterprise software, and healthcare sectors.
Organogenesis is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
